Epifoam NDC 0037-6824

NDC codes

FDA NDC Directory

Product NDC (as listed)0037-6824Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00037-6824Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0037-6824-10	00037682410	1 CANISTER in 1 CARTON (0037-6824-10) / 10 g in 1 CANISTERMarketed from Aug 25, 2014

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Epifoam
Generic name (nonproprietary): pramoxine hydrochloride and hydrocortisone acetate
Active ingredients: Pramoxine hydrochloride — 100 mg/10gHydrocortisone acetate — 100 mg/10g
Dosage form: Aerosol, Foam
Route: Topical
Labeler: Viatris Specialty LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 086457
Marketing start: Aug 25, 2014
Listing expires: Dec 31, 2026
Other FDA classes: Corticosteroid Hormone Receptor Agonists (Mechanism)
Identifiers: Product ID 0037-6824_c99db232-5398-45ed-a621-83448f51f5aeSPL ID c99db232-5398-45ed-a621-83448f51f5aeSPL set ID b22b8b41-2f1e-11e4-8c21-0800200c9a66RxCUI 904782, 904783UNII 88AYB867L5, 3X7931PO74
Pharmacologic class: Corticosteroid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400037682410 followed by a unit qualifier and the quantity

Package 00037-6824-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 15, 2024.

Indications (excerpt from the label)

INDICATIONS AND USAGE Topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)